EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Brain‐derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta‐analysis

Arman Shafiee iD, Kyana Jafarabady, Ida Mohammadi, Shahryar Rajai

Brain and Behavior · 2024-01 · 14 (1)

DOI: 10.1002/brb3.3349 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Brain and Behavior, online erschienen am 31.12.2023. Verfasst von Arman Shafiee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Mental Health, Alborz University of Medical Sciences, Karaj, Iran. Hauptthemen laut MEDLINE: Panic Disorder. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The existing literature on the association between brain‐derived neurotrophic factor (BDNF) protein levels and panic disorder presents inconsistent findings. This systematic review and meta‐analysis aim to synthesize the available evidence and determine the overall effect of BDNF protein levels in individuals diagnosed with panic disorder.

Methods

A comprehensive literature search was conducted using electronic databases (PubMed, Embase, Scopus, PsycINFO, and Web of Science) from inception to April 21, 2023. The search strategy included relevant keywords and medical subject headings terms related to BDNF, panic disorder, and protein levels. A random‐effects model was used for the meta‐analysis, and subgroup analyses were performed to explore heterogeneity. Publication bias was assessed using funnel plots and statistical tests.

Results

A total of 12 studies met the inclusion criteria. The meta‐analysis demonstrated a significant decrease in BDNF protein levels in individuals with panic disorder (SMD = −.53, 95% CI: −1.02 to −.04, p < .001; I 2 : 92%). The results of subgroup and meta‐regression analyses were not statistically significant. No significant publication bias was observed based on the results of Egger's regression test ( p ‐value = .3550).

Conclusion

This systematic review and meta‐analysis provide evidence of lower BDNF protein levels in individuals diagnosed with panic disorder compared to healthy controls. The findings suggest a potential role for BDNF dysregulation in the pathophysiology of panic disorder. Further research is warranted to elucidate the underlying mechanisms and potential therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Panic DisorderHumansBrain-Derived Neurotrophic FactorRegression Analysis

Stichwörter der Autor:innen

anxietybrain-derived neurotrophic factorpanic

Substanzen

Brain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Department of Psychiatry and Mental Health, Alborz University of Medical Sciences, Karaj, Iran.
  • Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Arman Shafiee

Zitieren

APA

Shafiee, A., Jafarabady, K., Mohammadi, I., & Rajai, S. (2024). Brain‐derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta‐analysis. Brain and Behavior, 14(1). https://doi.org/10.1002/brb3.3349

Vancouver

Shafiee A, Jafarabady K, Mohammadi I, Rajai S. Brain‐derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta‐analysis. Brain and Behavior. 2024;14(1). doi:10.1002/brb3.3349

BibTeX
@article{Shafiee2024,
  author = {Shafiee, Arman and Jafarabady, Kyana and Mohammadi, Ida and Rajai, Shahryar},
  title = {Brain‐derived neurotrophic factor (BDNF) levels in panic disorder: A systematic review and meta‐analysis},
  journal = {Brain and Behavior},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1002/brb3.3349}
}
Kostenlos starten →